Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp J Jost

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Cold Spring Harbor Perspectives in Biology|December 18, 2019
Regulation of Cell Death and Immunity by XIAPPhilipp J Jost, Domagoj Vucic
Hepatology (Baltimore, Md.)|February 18, 2010
Cancer caused by too much apoptosis--an intriguing contradiction?Philipp J Jost, Thomas Kaufmann
Blood|November 23, 2006
Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implicationsPhilipp J Jost, Jürgen Ruland
Cell Death and Differentiation|September 23, 2018
Necroinflammation emerges as a key regulator of hematopoiesis in health and diseasePhilipp J Jost, Ulrike Höckendorf
Molecular & Cellular Oncology|June 17, 2016
XIAP as a regulator of inflammatory cell death: the TNF and RIP3 angleMonica Yabal, Philipp J Jost
Oncotarget|August 13, 2016
RIPK3-dependent cell death and inflammasome activation in FLT3-ITD expressing LICsUlrike Höckendorf, Monica Yabal, Philipp J Jost
Cell Cycle (Georgetown, Tex.)|October 12, 2016
Killing AML: RIPK3 leads the wayUlrike Höckendorf, Monica Yabal, Philipp J Jost
Immunity|February 26, 2009
The many roles of FAS receptor signaling in the immune systemAndreas Strasser, Philipp J Jost, Shigekazu Nagata
BMC Nephrology|May 5, 2018
Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograftPhilipp Moog, Philipp J Jost, Maike Büttner-Herold
Cancers|February 12, 2021
Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung CancerElisabeth Smolle, Valentin Taucher, Joerg Lindenmann, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Cold Spring Harbor Perspectives in Biology|December 18, 2019
Regulation of Cell Death and Immunity by XIAPPhilipp J Jost, Domagoj Vucic
Hepatology (Baltimore, Md.)|February 18, 2010
Cancer caused by too much apoptosis--an intriguing contradiction?Philipp J Jost, Thomas Kaufmann
Blood|November 23, 2006
Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implicationsPhilipp J Jost, Jürgen Ruland
Cell Death and Differentiation|September 23, 2018
Necroinflammation emerges as a key regulator of hematopoiesis in health and diseasePhilipp J Jost, Ulrike Höckendorf
Molecular & Cellular Oncology|June 17, 2016
XIAP as a regulator of inflammatory cell death: the TNF and RIP3 angleMonica Yabal, Philipp J Jost
Oncotarget|August 13, 2016
RIPK3-dependent cell death and inflammasome activation in FLT3-ITD expressing LICsUlrike Höckendorf, Monica Yabal, Philipp J Jost
Cell Cycle (Georgetown, Tex.)|October 12, 2016
Killing AML: RIPK3 leads the wayUlrike Höckendorf, Monica Yabal, Philipp J Jost
Immunity|February 26, 2009
The many roles of FAS receptor signaling in the immune systemAndreas Strasser, Philipp J Jost, Shigekazu Nagata
BMC Nephrology|May 5, 2018
Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograftPhilipp Moog, Philipp J Jost, Maike Büttner-Herold
Cancers|February 12, 2021
Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung CancerElisabeth Smolle, Valentin Taucher, Joerg Lindenmann, et al.
Pageof 11